Search Results - "Uprichard, A C"

Refine Results
  1. 1

    H2-receptor antagonism is not pro-arrhythmic in a chronic canine model by UPRICHARD, A. C. G, HARRON, D. W. G

    Published in Basic research in cardiology (01-09-1990)
    “…Seven to 28 days after coronary artery ligation, programmed electrical stimulation was performed in conscious dogs. Groups of 6 previously inducible dogs in…”
    Get full text
    Journal Article
  2. 2

    Atenolol, but not mexiletine, protects against stimulus‐induced ventricular tachycardia in a chronic canine model by Uprichard, A.C.G., Harron, D.W.G.

    Published in British journal of pharmacology (01-01-1989)
    “…1 In a placebo‐controlled study of the antiarrhythmic and electrophysiological properties of atenolol and mexiletine, programmed electrical stimulation (PES)…”
    Get full text
    Journal Article
  3. 3

    Lp (a) lipoprotein and impaired glucose tolerance: Association poorly investigated by Uprichard, A C G, Shurzinske, L

    Published in BMJ (08-01-1994)
    “…[...]even with the appropriate statistics and more confident data,retrospective case-control studies such as this should at best generate hypotheses:…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Profibrillatory actions of pinacidil in a conscious canine model of sudden coronary death by Chi, L, Uprichard, A C, Lucchesi, B R

    Published in Journal of cardiovascular pharmacology (01-03-1990)
    “…Pinacidil is one of a number of new antihypertensive agents possessing an action that involves an enhanced potassium efflux in cardiac and vascular smooth…”
    Get more information
    Journal Article
  6. 6

    Discovery and development of an endothelin A receptor-selective antagonist PD 156707 by Doherty, A M, Uprichard, A C

    Published in Pharmaceutical biotechnology (1998)
    “…PD 156707 is a highly potent, selective antagonist of the ETA receptor that has demonstrated efficacy in a number of different disease models. The next few…”
    Get more information
    Journal Article
  7. 7

    Resolution and electrophysiological effects of mexiletine enantiomers by Turgeon, J, Uprichard, A C, Bélanger, P M, Harron, D W, Grech-Bélanger, O

    Published in Journal of pharmacy and pharmacology (01-09-1991)
    “…Resolution of mexiletine enantiomers from the racemic mixture has been achieved by fractional crystallization through the formation of diastereoisomeric…”
    Get more information
    Journal Article
  8. 8

    The QUinapril ischemic event trial (QUIET) design and methods : evaluation of chronic ACE inhibitor therapy after coronary artery intervention by TEXTER, M, LEES, R. S, PITT, B, DINSMORE, R. E, UPRICHARD, A. C. G

    Published in Cardiovascular drugs and therapy (01-04-1993)
    “…The rationale, trial design, and statistical aspects of QUIET, the QUinapril Ischemic Event Trial, are described. QUIET is a prospective, double-blind…”
    Get full text
    Journal Article
  9. 9

    Procainamide-associated blood dyscrasias by Danielly, Julie, DeJong, Richard, Radke-Mitchell, Lyn C., Uprichard, Andrew C.G.

    Published in The American journal of cardiology (01-12-1994)
    “…Despite the rarity of procainamide-associated bone marrow suppression, it is imperative that the patient and treating physician follow labeling precautions…”
    Get full text
    Journal Article
  10. 10

    Pharmacokinetic and pharmacodynamic comparisons of twice daily and four times daily formulations of procainamide in patients with frequent ventricular premature depolarization by Yang, B B, Abel, R B, Uprichard, A C, Smithers, J A, Forgue, S T

    Published in Journal of clinical pharmacology (01-07-1996)
    “…A study was conducted to evaluate the pharmacokinetics of procainamide and its active metabolite, N-acetylprocainamide (NAPA), as a function of dose and…”
    Get more information
    Journal Article
  11. 11
  12. 12

    Antiarrhythmic versus antifibrillatory actions: Inference from experimental studies by Lucchesi, Benedict R., Chi, Liguo, Friedrichs, Gregory S., Black, Shawn C., Uprichard, Andrew C.G.

    Published in The American journal of cardiology (26-11-1993)
    “…Pathophysiology of the coronary circulation is a major contributor to altering the myocardial substrate, rendering the heart susceptible to the onset of…”
    Get full text
    Journal Article Conference Proceeding
  13. 13

    Hypothyroidism renders protection against lethal ventricular arrhythmias in a conscious canine model of sudden death by Venkatesh, N, Lynch, J J, Uprichard, A C, Kitzen, J M, Singh, B N, Lucchesi, B R

    Published in Journal of cardiovascular pharmacology (01-11-1991)
    “…The protective effect of hypothyroidism against lethal ventricular tachyarrhythmias (VT) in the subacute phase of experimental myocardial infarction (MI) was…”
    Get more information
    Journal Article
  14. 14
  15. 15

    Effects of the positive inotropic agents milrinone and pimobendan on the development of lethal ischemic arrhythmias in conscious dogs with recent myocardial infarction by Lynch, Jr, J J, Uprichard, A C, Frye, J W, Driscoll, E M, Kitzen, J M, Lucchesi, B R

    Published in Journal of cardiovascular pharmacology (01-10-1989)
    “…The effects of milrinone and pimobendan upon the initiation of programmed ventricular stimulation-induced ventricular tachycardia (VT) and the incidence of…”
    Get more information
    Journal Article
  16. 16

    Effects of tocainide enantiomers on experimental arrhythmias produced by programmed electrical stimulation by Uprichard, A C, Allen, J D, Harron, D W

    Published in Journal of cardiovascular pharmacology (01-02-1988)
    “…The enantiomers of tocainide, a Class Ib antiarrhythmic agent, have recently been shown to exhibit differences in antiarrhythmic activity and pharmacokinetic…”
    Get more information
    Journal Article
  17. 17

    Alinidine reduces the incidence of ischemic ventricular fibrillation in a conscious canine model, a protective effect antagonized by overdrive atrial pacing by Uprichard, A C, Chi, L G, Lynch, J J, Driscoll, E M, Frye, J W, Lucchesi, B R

    Published in Journal of cardiovascular pharmacology (01-09-1989)
    “…The antiarrhythmic and antifibrillatory effects of the specific bradycardic agent alinidine were evaluated in a conscious canine model of myocardial infarction…”
    Get more information
    Journal Article
  18. 18

    Effects of combined thromboxane synthetase inhibition/thromboxane receptor antagonism in two models of sudden cardiac death in the canine: limited role for thromboxane by Kitzen, J M, Chi, L G, Uprichard, A C, Lucchesi, B R

    Published in Journal of cardiovascular pharmacology (01-07-1990)
    “…The effects of combined thromboxane synthetase inhibition and thromboxane receptor antagonism (TSI/TRA) were studied in conscious and in anesthetized canine…”
    Get more information
    Journal Article
  19. 19
  20. 20